Scemblix 40 MG tablet UU 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9HV0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,973
Award facts
- Contract value 100% obligated
- $13,973.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,973.47 for SCEMBLIX 40 mg tablets (60-count units) on December 30, 2025, with an ultimate completion date of January 22, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds significant standing as a critical federal medical procurement vendor. The company's extensive federal contract portfolio with the Defense Logistics Agency demonstrates its capability to supply a diverse range of pharmaceutical products across multiple therapeutic domains to support military and veteran healthcare systems. This delivery order for SCEMBLIX, a neurological treatment medication, reflects the company's ongoing role in fulfilling specialized pharmaceutical requirements for the Defense Health Agency and other federal healthcare customers through DLA's pharmaceutical prime vendor program.
Quick answers
Who was awarded contract SPE2DR26F9HV0?
SPE2DR26F9HV0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26F9HV0 worth?
The government has obligated $13,973 on SPE2DR26F9HV0.
Is contract SPE2DR26F9HV0 an order under another contract?
Yes. SPE2DR26F9HV0 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9HV0 competed?
The extent of competition for SPE2DR26F9HV0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award